Delivery Order SPE2DB22D6029-SPE2DB25FLVGH
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $6,223.32, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 15, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $9,023.13 firm fixed price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
The federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $6,555.96. The contract has an ultimate completion date of November 1, 2024 and is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite...
This federal contract award is for the delivery of RINVOQ ER 45 MG TABLET UU 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,020.55 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 3, 2024 with a completion date of June 4, 2024. The contract is a delivery order and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The $43,254.69 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024, with an ultimate completion date of October 22, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The contract, valued at $10,836.57, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00...
This federal contract award is for the delivery of 30mg RINVOQ ER tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $4,811.33. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 14, 2023, with a ceiling value of $23,835.60 and a completion date of March 15, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $10,764.91 firm-fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 12, 2024 and was awarded on March 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This contract award is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $11,615.01, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price Delivery Order with an ultimate completion date of December 27, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite...